Paul Saladino· MD
if we look at its beneficial effects it doesn't seem to specifically lower all cause mortality
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
if we look at its beneficial effects it doesn't seem to specifically lower all cause mortality
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the result for the other key secondary end points fatal or non-fatal stroke and death from any cause did not differ significantly between the bidic acid group and the placebo group